A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or ...
The FDA approval of Awiqli is a ‘huge deal’ for people looking for an alternative to daily shots, experts say. The FDA just approved Awiqli, a once-weekly insulin treatment for type 2 diabetes. Awiqli ...
Tirzepatide's uptake was rapid post-launch, surpassing other GLP-1 RAs and SGLT2 inhibitors, while conventional GLMs like metformin and insulin declined. The approval of tirzepatide for type 2 ...
Share on Pinterest Scientists are working on alternatives to drugs like Ozempic to treat diabetes and obesity. Westend61/Getty Images A new study published by Swedish researchers shared results of the ...
A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new research which looked at data from more than 300,000 patients who have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results